Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6337)
All Articles published online
|
Publishing Process of This Article
|
Aug 16, 2013 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Biagetti B, Corcoy R. Hypoglycemia associated with fluoxetine treatment in a patient with type 1 diabetes. World J Clin Cases 2013; 1(5): 169-171 [PMID: 24303494 DOI: 10.12998/wjcc.v1.i5.169] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v1/i5/169.htm |
| Number | Citing Articles |
| 1 |
Redouane Rebai, Luc Jasmin, Abdennacer Boudah. The antidepressant effect of melatonin and fluoxetine in diabetic rats is associated with a reduction of the oxidative stress in the prefrontal and hippocampal cortices. Brain Research Bulletin 2017; 134: 142 doi: 10.1016/j.brainresbull.2017.07.013
|
| 2 |
Nirmal Singh, Aditya Khetan, Rishab Gupta. Chasing the Offending Medication. Journal of Clinical Psychopharmacology 2021; 41(6): 698 doi: 10.1097/JCP.0000000000001462
|
| 3 |
Seunghee Han, Hye-Sun Park, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha. Paroxetine-induced Hypoglycemia in Type 2 Diabetic Patient. The Ewha Medical Journal 2016; 39(1): 14 doi: 10.12771/emj.2016.39.1.14
|
| 4 |
Bo Liu, Inmaculada Ruz‐Maldonado, Klaudia Toczyska, Oladapo E. Olaniru, Mohammed Gulrez Zariwala, David Hopkins, Min Zhao, Shanta J. Persaud. The selective serotonin reuptake inhibitor fluoxetine has direct effects on beta cells, promoting insulin secretion and increasing beta‐cell mass. Diabetes, Obesity and Metabolism 2022; 24(10): 2038 doi: 10.1111/dom.14791
|
| 5 |
Nahi Sabih Alruwaili, Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Ali K. Albuhadily, Amany E. Ragab, Ahmad Awad Alenazi, Athanasios Alexiou, Marios Papadakis, Gaber El-Saber Batiha. Antidepressants and type 2 diabetes: highways to knowns and unknowns. Diabetology & Metabolic Syndrome 2023; 15(1) doi: 10.1186/s13098-023-01149-z
|
| 6 |
Zhi-Kun Qiu, Jia-Li He, Xu Liu, Guan-Hua Zhang, Jia Zeng, Hong Nie, Yong-Gang Shen, Ji-Sheng Chen. The antidepressant-like activity of AC-5216, a ligand for 18KDa translocator protein (TSPO), in an animal model of diabetes mellitus. Scientific Reports 2016; 6(1) doi: 10.1038/srep37345
|
| 7 |
Julia K. Panzer, Alejandro Caicedo. Targeting the Pancreatic α-Cell to Prevent Hypoglycemia in Type 1 Diabetes. Diabetes 2021; 70(12): 2721 doi: 10.2337/dbi20-0048
|
| 8 |
Surachai Ngamratanapaiboon, Krittaboon Pornchokchai, Siriphattarinya Wongpitoonmanachai, Petchlada Pholkla, Napatarin Srikornvit, Jiajun Mo, Patipol Hongthawonsiri, Pracha Yambangyang, Pilaslak Akrachalanont. Metabolomic identification of biochemical changes induced by fluoxetine in an insulinoma cell line (MIN6). Research in Pharmaceutical Sciences 2023; 18(5): 517 doi: 10.4103/1735-5362.383707
|
| 9 |
Kibret Enyew Belay, Beza Leulseged Ayalew, Abdissa Meherete Etana, Mohammadjavad Ashrafi Mahabadi. Extremely high-dose insulin requirement in a diabetic patient with psychiatric illness: A case report. SAGE Open Medical Case Reports 2023; 11 doi: 10.1177/2050313X231220834
|
| 10 |
Carolina Ruiz‑Santiago, Carla Rodríguez‑Pinacho, Gilberto Pérez‑sánchez, Erika Acosta‑cruz. Effects of selective serotonin reuptake inhibitors on endocrine system (Review). Biomedical Reports 2024; 21(3) doi: 10.3892/br.2024.1816
|
| 11 |
José Ángel García-Pedraza, Cristina López, Juan Francisco Fernández-González, María Luisa Martín, Asunción Morán, Mónica García-Domingo. Vascular sympathetic neurotransmission and its serotonergic regulation are modified by chronic fluoxetine treatment. Journal of Pharmacological Sciences 2021; 147(1): 48 doi: 10.1016/j.jphs.2021.05.008
|
| 12 |
Zizhen Zhang, Yang Du, Lizhi Chen, Ying Liu, Biao Du. Effects of the selective serotonin reuptake inhibitor fluoxetine on glucose metabolism: A systematic review. Asian Journal of Psychiatry 2022; 73: 103092 doi: 10.1016/j.ajp.2022.103092
|
| 13 |
José Ángel García-Pedraza, Juan Francisco Fernández-González, Cristina López, María Luisa Martín, Claudia Alarcón-Torrecillas, Alicia Rodríguez-Barbero, Asunción Morán, Mónica García-Domingo. Oral fluoxetine treatment changes serotonergic sympatho-regulation in experimental type 1 diabetes. Life Sciences 2022; 293: 120335 doi: 10.1016/j.lfs.2022.120335
|
| 14 |
Isabelle Austin-Zimmerman, Marta Wronska, Baihan Wang, Haritz Irizar, Johan H. Thygesen, Anjali Bhat, Spiros Denaxas, Ghazaleh Fatemifar, Chris Finan, Jasmine Harju-Seppänen, Olga Giannakopoulou, Karoline Kuchenbaecker, Eirini Zartaloudi, Andrew McQuillin, Elvira Bramon. The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics. Genes 2021; 12(11): 1758 doi: 10.3390/genes12111758
|
| 15 |
Joana Almaça, Judith Molina, Danusa Menegaz, Alexey N. Pronin, Alejandro Tamayo, Vladlen Slepak, Per-Olof Berggren, Alejandro Caicedo. Human Beta Cells Produce and Release Serotonin to Inhibit Glucagon Secretion from Alpha Cells. Cell Reports 2016; 17(12): 3281 doi: 10.1016/j.celrep.2016.11.072
|